Norin Merchant’s Post

📢 Transitioning to New Horizons: A Grateful Journey After seven years with uniQure, it's time for me to bid farewell. I'm filled with a mix of emotions—excitement for the future and gratitude for the incredible journey I've had at uniQure. Working at uniQure has been an absolute honor. Navigating unique challenges, we delivered exceptional projects, from the transition of AMT-060 to AMT-061 leading to HEMGENIX, Huntington’s first clinical trial and the latest IND approvals of TLE and Fabry programs. The lessons learned, the challenges met, and the friendships formed have made this chapter in my career truly special. During my time at Uniqure, I've had the chance to evolve, adapt, and thrive in various capacities—managing different teams, stepping into diverse roles, and immerse myself in the intricacies of drug development. In addition, I had the opportunity to engage in my EMBA that further broadened my horizons, and I'm excited to carry these lessons into the next phase of my journey. Beyond my own personal and professional development, I also realized that my greatest investment has been in the growth and development of the people around me. Witnessing team members pursue higher education, grow within their roles, and expand their skills has been fulfilling and the heartbeat of our shared success. As I transition into a new chapter, I want to express my deepest gratitude to the Uniqure team — colleagues, mentors, and friends—who made this journey memorable. Here's to continuous learning and future adventures! 🌐🔬 #BiotechJourney #Gratitude #CareerTransition #PeopleDevelopment #LeadershipDevelopment #MissionDriven

🏆 Celebrating Transformational Deals in Life Sciences! 🏆 We're thrilled to invite nominations for the Deal of the Year >€500m award at the European Lifestars Awards!  This award recognizes the teams and organizations that have executed a transformational high-value deal, significantly impacting both the company and the wider industry. Whether it's a licensing agreement, co-development, or partnership, we want to celebrate your success! This prestigious award acknowledges deals that excel in: 🌟 Uniqueness or novelty of deal strategy, terms, and structure 💶 Level of value creation and size of the deal 🤝 Strength of partner, partnership, and deal teams 🔮 Potential game-changing implications within the next 12 months 📈 Post-deal performance To qualify, deals must: - Have a total deal size (not milestone payments) greater than €500m - Involve a European Life Science company as the lead - Be open to private or public companies with pharma, commercial leaders, or big tech - Be a license, partnership, or alliance between companies (NOT M&A) - Have completed between 1 September 2023 and 1 August 2024 Nominate a deserving team today and help us honor their groundbreaking achievements and contributions to the European life sciences industry! 👉 Submit your nomination here: https://lnkd.in/ezjTkn6f ✨ Get inspired by last year’s winner: Watch the video of Quell Therapeutics and AstraZeneca’s success story, then nominate this year’s standout performer! #LifestarsAwards #DealOfTheYear #Innovation #LifeSciences

Noteworthy Biopharma Moves from Last Week 🔍 (Insights you don't want to miss) Last week saw significant leadership changes within the biopharma sector. Here's a quick roundup of key appointments and promotions: 1. Sanofi: Audrey Duval Derveloy - Executive VP, Global Head of Corporate Affairs 2. Lupin: Abdelaziz Toumi - CEO, manufacturing solutions subsidiary 3. Arvinas: Ian Taylor - President, Research and Development 4. MyMD Pharmaceuticals: Mitchell Glass - President and Chief Medical Officer 5. CytomX Therapeutics: Chris Ogden - Chief Financial Officer 6. Seaport Therapeutics: - Antony Loebel - Chief Medical Officer and President, Clinical Development - Lana Gladstein - General Counsel 7. Shuttle Pharmaceuticals: - Timothy Lorber - Chief Financial Officer - Michael Vander Hoek - VP, Regulatory 8. Firefly Neuroscience: Samer Kaba - Chief Medical Officer 9. Regel Therapeutics: Stephen Furr - Chief Executive Officer 10. AGC Biologics: Ben Clauberg - VP, Business Development 11. QPS: Derek Grimes - Executive VP and Global Head of Clinical Research 12. Ironwood Pharmaceuticals: Sravan Emany - Senior VP, Chief Operating Officer, and CFO P.S. If you found this roundup insightful, don't forget to share it with your network. #Biopharma #IndustryInsights

Thoughts on this? >> Parexel CEO to retire; CAR-T maker AffyImmune promotes business leader to chief executive >> Comment below! >>> lqventures.com #strategy #competitiveintelligence #marketing #biotech #productmarketing #healthcare #pharmaceutical #pharma

"My time here has been good. It has been full of learning, ups and downs, but most of all, it has been memorable. Every time I have come across something new, I have learned. And these learnings have given me a versatility that is beyond the confines of a specific role or scope of work. I have been part of new product launches and operations. Listening to the stockists gives me insights and makes them feel heard. Meeting people, and learning new things is something I find fun. When the new systems were introduced, I again adapted, and combined with my strengths, tackled them confidently. One because I believe in myself, and two, because of the GTLL family behind me. Samay ka andaza nahi hua aur 20 saal nikal gaye. And the best part is, I am excited for the future. Kaafi kuch aur karna hai. Abhi picture baaki hai mere dost." . #40YearsOfTerce #TerceFoundationWeek #FoundationWeek #40thFoundationWeek #40YearsOfPharma #Pharmaceuticals #IndianPharma

During my undergraduate studies, I aimed to work in the biotech 💉 industry. Since pivoting into the legal ⚖ practice, I'm all-the-more happy to have landed at Fenwick & West, which has a dual-focus on both the general tech sector and the life sciences sector. This duality has shaped my own patent prosecution practice with a core focus on the overlap of machine-learning techniques as applied to biotech research & development. 🏆 🎉 #LifeSciences #Healthtech #PGOTY

Fantastic! And where can you read about this? On Law360 on LexisNexis!

Thoughts on this? >> Parexel CEO to retire; CAR-T maker AffyImmune promotes business leader to chief executive >> Comment below! >>> lqventures.com #strategy #competitiveintelligence #marketing #pharma #biotech #healthcare #pharmaceutical #productmarketing

"Happy 6th Company Anniversary! 🎉🥳 Today marks another milestone in our journey together. From humble beginnings to remarkable achievements, each step has been a testament to our collective dedication and hard work. We have conquered challenges, celebrated victories, and grown stronger as a team/company with learning experiences and customer feedbacks. We continue to innovate, inspire, and exceed expectations in the years ahead. Welcome many more successes together! Cheers to us! 🚀 #TeamSuccess #6thAnniversaryCelebration"

Grateful will fall short to represent how I feel after this 3-days experience to explore, engage & commit to act to shape the future of Sanofi. But the road is paved with challenges in an environment changing faster than ever, powered by IA spreading at light speed as a tsunami we are learning to surf while it shifts our current paradigms in weeks, patients are empowered & expecting more from our industry & our mission is bold. But I believe we will transform those into opportunities to become the first IA powered biopharma to change the practice of medicine. Sounds exciting to you? To me: mission accepted! For that, my 2 commitments to achieve: 1. Define my impact lever & stick to it without compromising. 2. Influence others to embark together on the journey. The Ingredients for success: that have been reinforced through the activities & interactions? - Keep exploring the value chain to excel at connecting the dots as I already love to do. - Untap the real potential of our best assets: human networking to think solutions differently, to learn from each other’s situations & to reflect together. - Enhance the use of IA to generate additional added value at the service of our patients. - Uncover my full internal power through self-discovering journey & skills mastery to bring my mission to live courageously. I truly believe that contributing to this mission will not only grow me as a professional & personally but that we will all feel transformed, purposeful & proud.